Thorben Seeger retweeted
Alphabet's Verily covered up HIPAA violations, whistleblower says in lawsuit cnbc.com/2025/09/11/alphabet…
Thorben Seeger retweeted
A whistleblower says Alphabet’s Verily hid HIPAA breaches impacting 25,000+ patients. The cover-up case is now in court. f-st.co/tZnN62X
Thorben Seeger retweeted
Alphabet's Verily covered up HIPAA violations, whistleblower says in lawsuit cnbc.com/2025/09/11/alphabet…
Thorben Seeger retweeted
#三井情報 は、英国の Lifebit Biotech Limitedと「Lifebitプラットフォーム」におけるサービスパートナー契約を締結し、2025年7月より提供を開始しました。
mki.co.jp/news/solution/2025…
今後、三井情報はLifebit Biotechと連携のもと、国内のバイオバンク、製薬企業等との協業を推進し、標準化されたバイオメディカルデータ解析基盤を各組織の状況に合わせて柔軟に導入・展開する取り組みを進めます。
これにより、創薬およびライフサイエンス分野における研究開発のさらなる発展と加速を目指します。
#MKI #Lifebit #創薬 #研究開発
Great piece on our key partnership with the @23andMe led @LCGeneticsStudy to drive #LungCancer #Research on @lifebitAI’s #TrustedResearchEnvironment #TRE
pharmaceuticalmanufacturer.m…
Great piece on our key partnership with @CR_Horizons to maximise the impact of data generated through @CR_UK via the @lifebitAI Federated Data Network & #TrustedResearchEnvironment #genomics #rwd #cancerresearch #Oncology
ddw-online.com/partnership-w…
Interesting deep dive: "Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan - ESMO Real World Data and Digital Oncology" by @flatironhealth featuring the @lifebitAI #federated #TrustedResearchEnvironment #TRE #RWE #RWD esmorwd.org/article/S2949-82…
Thorben Seeger retweeted
The @LCGeneticsStudy is getting stronger! New technology partnership announcement marks a major step forward. Encourage anyone diagnosed in the US to take part.
Learn more:
einnews.com/pr_news/78463707…
#LCSM
Thorben Seeger retweeted
Fantastic to see the next step in the @LCGeneticsStudy. They've teamed up with @lifebitAI to build a new secure platform to help analyse data from 10,000 lung cancer patients by 2027.
If you've been diagnosed with lung cancer, you can help too!
More at👇
einnews.com/pr_news/78463707…
Thorben Seeger retweeted
Today's announcement marks a major step forward for the @23andMe Lung Cancer Genetics Study! A new secure platform will help approved non-profit researchers access and analyze data from 10,000 participants at no cost.
Read the full story: apnews.com/press-release/ein… #LCSM
Thorben Seeger retweeted
Lifebit, Psifas Partner to Advance Personalized Medicine Initiative in Israel genomeweb.com/business-news/…
Lovely article by @GenomeWeb on our newest partnership with Psifas, Israeli Genomic Medicine Initiative
genomeweb.com/business-news/…
Proud that the Israeli Genomic Medicine Initiative Psifas has chosen @lifebitAI
Empowering advancements in personalised medicine by providing a secure & unified platform for clinical-genomic research across Israel’s diverse population
lifebit.ai/blog/lifebit-psif… #genomics #tre
News! @23andMe has chosen @lifebitAI's leading Trusted Research Environment to enable external research partners identify novel disease biology, discover potential new drug targets, & add genetic evidence into research programs to boost clinical success investors.23andme.com/news-r…
Introducing our Lifebit Clinical Portal v2! With advanced AI and seamless EHR & genomic data integration, this platform leads the way in precision medicine for healthcare. Visit @lifebitAI's blog to understand how we’re driving better health outcomes: bit.ly/3WaBSOk
Effective patient recruitment and enrollment are vital for clinical trials. @lifebitAI's latest blog highlights innovative solutions to enhance efficiency and diversity. Streamline processes, cut costs and speed up drug approvals: bit.ly/3W5y6Wy #Lifebit
Revisit @lifebitAI’s blog on how federated data analysis is revolutionising genomics research! Learn how secure data access enhances global collaboration & is enabling breakthroughs in diagnostics and targeted therapies: bit.ly/3L9g9Ap #Lifebit
Explore the depths of drug discovery challenges in @lifebitAI's insightful blog. Investigate how AI & ML in Drug Discovery 2.0 are positioned to redefine the sector and unlock the doors to a transformative era in drug development! hubs.li/Q02Ccztl0 #Lifebit
Excited to share insights from @lifebitAI’s blog on Trusted Research Environments (TREs) in the UK. Discover how TREs provide secure, efficient access to sensitive health data: bit.ly/45wWZxA #TRE #DataSecurity #HealthData #Lifebit
















